WoS Publication RDF
pages:- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- more...
- In Reply II-Prescribing More Stringent Design of Randomized Clinical Trials of Omega-3 Polyunsaturated Fatty Acids Article
- In Reply to the Letter to the Editor Regarding "Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community" Article
- In Reply-Association Between Weekly Exercise Time and Mortality Article
- In Reply-Association of Coffee Consumption With All-Cause and Cardiovascular Disease Mortality Article
- In reply-Atrial Fibrillation and Morbidity and Mortality in Stress-Induced Cardiomyopathy Article
- In Reply-Atrial Fibrillation: Interatrial Block May Be an Underdiagnosed and Easily Recognizable Risk Factor Article
- In reply-Is Coffee Harmful? If Looking for Longevity, Say Yes to the Coffee, No to the Sugar Article
- In reply-Regarding L-Carnitine and Cardiovascular Disease Article
- In reply-Resistance Training and Cancer Survival Article
- In Reply: ACEI and ARB - Each Unique RAAS Inhibitors: The Importance of Impact on Inflammation Article
- In reply: Impaired myocardial blood flow in atrial fibrillation Article
- In Reply: Ventral Subaxial Cervical Access Using Tailored Access Osteotomies, A Cadaveric Study Article
- In Reply: Ventral Subaxial Cervical Access Using Tailored Access Osteotomies, A Cadaveric Study Article
- In Response to "Polypoid Change of the Middle Turbinate and Paranasal Sinus Polyposis Are Distinct Entities" Article
- In response to: lifestyle medicine in Expert Review of Cardiovascular Therapy Article
- In support of ICRP's call to action to strengthen expertise in radiological protection worldwide Article
- In vitro antibacterial activity of tigecycline against resistant Gram-negative bacilli and enterococci by time-kill assay Article
- IN VITRO ANTIBACTERIAL ACTIVITY OF TIGECYCLINE BY TIME-KILL ASSAY AGAINST LINEZOLID-SUSCEPTIBLE AND -RESISTANT VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM Article
- IN VITRO INTERACTION OF LEFAMULIN, A PLEUROMUTILIN ANTIBIOTIC, AND DOXYCYCLINE AGAINST LINEZOLID- AND VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM Article
- In Vitro Lymphocyte Functions in Undernourished Children With Sickle Cell Anemia Article
- IN VITRO SYNERGISM OF FLUCONAZOLE PLUS POLYMYXIN B AGAINST CANDIDA AURIS Article
- IN VITRO SYNERGISTIC ACTIVITY OF CASPOFUNGIN AND POLYMYXIN B AGAINST FLUCONAZOLE-RESISTANT CANDIDA GLABRATA Article
- In Vitro Synergistic Activity of Caspofungin Plus Plymyxin B Against Fluconazole-Resistant Article
- In vitro synergistic cellular proliferation inhibition in pancreatic cancer cells Su86 and Mia-PaCa-2 with fluvastatin and nab-paclitaxel. Article
- In vitro synergistic/additive activity of levofloxacin with meropenem against Stenotrophomonas maltophilia Article
- IN VITRO SYNERGY OF FOSFOMYCIN PLUS DOXYCYCLINE AGAINST LINEZOLID AND VANCOMYCIN RESISTANT ENTEROCOCCUS FAECIUM USING A RAPID ETEST METHOD AND TIME-KILL ASSAY Article
- In Vitro Synergy of Telavancin and Rifampin Against Enterococcus faecium Resistant to Both Linezolid and Vancomycin Article
- In vitro synergy with fluconazole plus doxycycline or tigecycline against clinical Candida glabrata isolates Article
- In vitro synergy with fosfomycin plus doxycyclin against linezolid and vancomycin-resistant Enterococcus faecium Article
- In vitro testing of daptomycin plus rifampin against methicillin-resistant Staphylococcus aureus resistant to rifampin Article